These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8899806)

  • 1. EM523L, a nonpeptide motilin agonist, stimulates gastric emptying and pancreatic polypeptide secretion.
    Okano H; Inui A; Ueno N; Morimoto S; Ohmoto A; Miyamoto M; Aoyama N; Nakajima Y; Baba S; Kasuga M
    Peptides; 1996; 17(6):895-900. PubMed ID: 8899806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromycin derivative improves gastric emptying and insulin requirement in diabetic patients with gastroparesis.
    Ishii M; Nakamura T; Kasai F; Baba T; Takebe K
    Diabetes Care; 1997 Jul; 20(7):1134-7. PubMed ID: 9203450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravenous administration of EM523L on gastric emptying and plasma glucose levels after a meal in patients with diabetic gastroparesis: a pilot study.
    Nakamura T; Ishii M; Arai Y; Tandoh Y; Terada A; Takebe K
    Clin Ther; 1994; 16(6):989-99. PubMed ID: 7697695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa.
    Stacher G; Peeters TL; Bergmann H; Wiesnagrotzki S; Schneider C; Granser-Vacariu GV; Gaupmann G; Kugi A
    Gut; 1993 Feb; 34(2):166-72. PubMed ID: 8432466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study.
    McCallum RW; Cynshi O;
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1121-30. PubMed ID: 17894654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
    Talley NJ; Verlinden M; Geenen DJ; Hogan RB; Riff D; McCallum RW; Mack RJ
    Gut; 2001 Sep; 49(3):395-401. PubMed ID: 11511562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers.
    Verhagen MA; Samsom M; Maes B; Geypens BJ; Ghoos YF; Smout AJ
    Aliment Pharmacol Ther; 1997 Dec; 11(6):1077-86. PubMed ID: 9663833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis.
    Russo A; Stevens JE; Giles N; Krause G; O'Donovan DG; Horowitz M; Jones KL
    Aliment Pharmacol Ther; 2004 Aug; 20(3):333-8. PubMed ID: 15274670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of motilin on gastric emptying in patients with diabetic gastroparesis.
    Peeters TL; Muls E; Janssens J; Urbain JL; Bex M; Van Cutsem E; Depoortere I; De Roo M; Vantrappen G; Bouillon R
    Gastroenterology; 1992 Jan; 102(1):97-101. PubMed ID: 1727784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies.
    Janssens J; Peeters TL; Vantrappen G; Tack J; Urbain JL; De Roo M; Muls E; Bouillon R
    N Engl J Med; 1990 Apr; 322(15):1028-31. PubMed ID: 2320062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric emptying and symptoms of bulimia nervosa: effect of a prokinetic agent.
    Devlin MJ; Kissileff HR; Zimmerli EJ; Samuels F; Chen BE; Brown AJ; Geliebter A; Walsh BT
    Physiol Behav; 2012 May; 106(2):238-42. PubMed ID: 22361261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: a randomized clinical trial.
    Burt M; Scott A; Williard WC; Pommier R; Yeh S; Bains MS; Turnbull AD; Fortner JG; McCormack PM; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1996 Mar; 111(3):649-54. PubMed ID: 8601981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic polypeptide secretion in diabetic patients with delayed gastric emptying and autonomic neuropathy.
    Loba JM; Saryusz-Wolska M; Czupryniak L; Kukulski K
    J Diabetes Complications; 1997; 11(6):328-33. PubMed ID: 9365873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy.
    Kawagishi T; Nishizawa Y; Okuno Y; Sekiya K; Morii H
    Am J Gastroenterol; 1993 Jun; 88(6):933-8. PubMed ID: 8503391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs.
    Sato F; Marui S; Inatomi N; Itoh Z; Omura S
    Eur J Pharmacol; 2000 Apr; 395(2):165-72. PubMed ID: 10794824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    Dig Dis Sci; 1999 Jun; 44(6):1100-6. PubMed ID: 10389679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nonpeptide motilin agonist EM523 on release of gut and pancreatic hormones in conscious dogs.
    Shiba Y; Mizumoto A; Satoh M; Inui A; Itoh Z; Omura S
    Gastroenterology; 1996 Jan; 110(1):241-50. PubMed ID: 8536863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacodynamics, safety and pharmacokinetics of single doses of the motilin agonist, camicinal, in type 1 diabetes mellitus with slow gastric emptying.
    Hellström PM; Tack J; Johnson LV; Hacquoil K; Barton ME; Richards DB; Alpers DH; Sanger GJ; Dukes GE
    Br J Pharmacol; 2016 Jun; 173(11):1768-77. PubMed ID: 26924243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus.
    Schirra J; Leicht P; Hildebrand P; Beglinger C; Arnold R; Göke B; Katschinski M
    J Endocrinol; 1998 Jan; 156(1):177-86. PubMed ID: 9496247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.